$5 Million Boost For Type 1 Diabetes Research At UC San Diego

Links shared publicly online about this topic.

838
total visits

$5 Million Boost For Type 1 Diabetes Research At UC San Diego

Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta C

View full resource at medicalnewstoday.com

Tags: Diabetes, Type 1 Diabetes, Children's Health, Education, Medical

Most Recently Shared on September 29, 2010 at 4:32 pm By:

Scott Strumello

$5 Million Boost For Type 1 Diabetes Research At UC San Diego http://t.co/KLn4jZm via @mnt_diabetes

2 years ago...

Retweet

Favorite

Also Shared By:

MNT Stem Cell News

MNT Diabetes News

Type 1 Diabetes Research at UC San Diego Gets $5 Million Boost

newswise.com — “Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.” View full resource at newswise.com

Most Recently Shared on October 1, 2010 at 5:44 pm By:

newswise Health News and Health Communicator

Type 1 Diabetes Research at UC San Diego Gets $5 Million Boost: Maike Sander, MD, associate professor of pediatric... http://bit.ly/9tweRq

2 years ago...

Retweet

Favorite

$5 Million Boost For Type 1 Diabetes Research At UC San Diego - QualityPoint Technologies

qualitypointtech.net — “Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes. Sander will lead a team of domestic and international collaborators, with the aim of generating replacement insulin-producing beta cells from patient-derived induced pluripotent stem cells...” View full resource at qualitypointtech.net